Results 151 to 160 of about 5,427 (217)

Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler (R) [PDF]

, 2000
BENGTSSON, T, BORGSTROM, L, Derom, Eric, Pauwels, Romain   +3 more
core   +1 more source

Peer review of the pesticide risk assessment of the active substance paraffin oil (CAS 64742‐46‐7, chain lengths C16–C25)

EFSA Journal, Volume 24, Issue 2, February 2026.
Abstract The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State Greece and co‐rapporteur Member State France for the pesticide active substance paraffin oil CAS 64742‐46‐7 are reported.
European Food Safety Authority (EFSA), Fernando Álvarez, Maria Arena, Domenica Auteri, Sofia Batista Leite, Amarela Becirovic, Marco Binaglia, Anna Federica Castoldi, Arianna Chiusolo, Angelo Colagiorgi, Mathilde Colas, Federica Crivellente, Chloe De Lentdecker, Isabella De Magistris, Mark Egsmose, Gabriella Fait, Franco Ferilli, German Giner Santonja, Varvara Gouliarmou, Katrin Halling, Alessio Ippolito, Frederique Istace, Dimitra Kardassi, Aude Kienzler, Anna Lanzoni, Roberto Lava, Renata Leuschner, Alberto Linguadoca, Mariano Lopez Romano, Jochem Louisse, Christopher Lythgo, Oriol Magrans, Iris Mangas, Andrea Mioč, Ileana Miron, Tunde Molnar, Laura Padovani, Vincenzo Padricello, Martina Panzarea, Juan Manuel Parra Morte, Simone Rizzuto, Miguel Santos, Rositsa Serafimova, Rachel Sharp, Csaba Szentes, Anne Theobald, Manuela Tiramani, Giorgia Vianello, Laura Villamar‐Bouza   +48 more
wiley   +1 more source

Updated peer review of the pesticide risk assessment of the active substance dichlorprop‐P and variant dichlorprop‐P‐2‐ethylhexyl

EFSA Journal, Volume 24, Issue 2, February 2026.
Abstract The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State, Ireland and co‐rapporteur Member State, Poland, for the pesticide active substance dichlorprop‐P and the variant dichlorprop‐P‐2‐ethylhexyl and the assessment of applications for maximum
European Food Safety Authority (EFSA), Fernando Álvarez, Maria Arena, Domenica Auteri, Sofia Batista Leite, Marco Binaglia, Anna Federica Castoldi, Arianna Chiusolo, Angelo Colagiorgi, Mathilde Colas, Federica Crivellente, Chloe De Lentdecker, Isabella De Magistris, Mark Egsmose, Gabriella Fait, Franco Ferilli, German Giner Santonja, Varvara Gouliarmou, Katrin Halling, Alessio Ippolito, Frederique Istace, Dimitra Kardassi, Aude Kienzler, Anna Lanzoni, Roberto Lava, Renata Leuschner, Alberto Linguadoca, Mariano Lopez Romano, Jochem Louisse, Christopher Lythgo, Oriol Magrans, Iris Mangas, Silvia Mazzega, Andrea Mioč, Ileana Miron, Tunde Molnar, Laura Padovani, Vincenzo Padricello, Martina Panzarea, Juan Manuel Parra Morte, Simone Rizzuto, Miguel Santos, Rositsa Serafimova, Rachel Sharp, Csaba Szentes, Anne Theobald, Manuela Tiramani, Giorgia Vianello, Laura Villamar‐Bouza, Marija Blazevic   +49 more
wiley   +1 more source

Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)

Respirology, Volume 31, Issue 2, Page 135-140, February 2026.
David M. G. Halpin, Refiloe Masekela, Claus F. Vogelmeier, Obianuju B. Ozoh, Alvaro A. Cruz, Helen K. Reddel, Arzu Yorgancıoğlu, Alvar Agusti, on behalf of the Boards of Directors of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and Global Initiative for Asthma (GINA), Alvar Agusti, Bartolome R. Celli, Gerard Criner, David Halpin, Maria Montes de Oca, Obianuju B. Ozoh, Sundeep Salvi, Claus Vogelmeier, Jinping Zheng, Arzu Yorgancioglu, Keith Allan, Guy Brusselle, Muhwa Jeremiah Chakaya, Alvaro A. Cruz, Hiromasa Inoue, Jerry A. Krishnan, Mark L. Levy, Helen K. Reddel   +26 more
wiley   +1 more source

425 Ensuring safe use of pressurised metered dose inhalers without a built-in dose counter

BMJ Paediatrics Open, 2021
Oon Hoe Teoh, Soh Yan Tan, Mary Hoon, Yi Hua Tan, Ai Huay Teo, Zai Ru Cheng   +5 more
doaj   +1 more source

Generic salbutamol metered dose inhalers. [PDF]

Thorax, 1995
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pressurized Metered-Dose Inhalers

2019
Pressurized Metered-dose Inhalers (pMDIs) are complex drug-device combination products that are widely used to treat lung diseases, and may also be advantageously employed to deliver active pharmaceutical ingredients (APIs) to the systemic circulation through the lungs. pMDIs occupy ca.
Sandro R.P. da Rocha, Balaji Bharatwaj, Rodrigo S. Heyder, Lin Yang   +3 more
openaire   +1 more source

The rejuvenated pressurised metered dose inhaler

Expert Opinion on Drug Delivery, 2007
The pressurised metered-dose inhaler (pMDI) has now been available for 50 years. Once regarded as an inefficient and difficult-to-use device, the technology has evolved significantly over the last few years, particularly since the introduction of novel formulations containing hydrofluoroalkane (HFA) propellants.
John, Bell, Steve, Newman
openaire   +2 more sources

Understanding pressurized metered dose inhaler performance

Expert Opinion on Drug Delivery, 2014
Deepening the current understanding of the factors governing the performance of the pressurized metered dose inhaler (pMDI) has the potential to benefit patients by providing improved drugs for current indications as well as by enabling new areas of therapy.
James W, Ivey, Reinhard, Vehring, Warren H, Finlay   +2 more
openaire   +2 more sources

Pressurized Metered Dose Inhaler Technology: Manufacturing

AAPS PharmSciTech, 2019
While first introduced in the 1950s, pressurized metered dose inhalers (pMDIs) remain as a first line treatment of pulmonary conditions. With expanding applications of pMDIs beyond asthma and chronic obstructive pulmonary disease (COPD), the development of therapies utilizing the pMDI platform will undoubtedly continue.
Ernest Vallorz, Poonam Sheth, Paul Myrdal   +2 more
openaire   +2 more sources